Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janice M Kerr

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Endocrine|March 22, 2012
Clinical implications of growth hormone-secreting tumor subtypesKatja Kiseljak-Vassiliades, Shibana Shafi, Janice M Kerr, et al.
Journal of Neurosurgery|August 31, 2010
Transsphenoidal resection of 82 Rathke cleft cysts: limited value of alcohol cauterization in reducing recurrence ratesKevin O Lillehei, Lars Widdel, Carolina A Arias Astete, et al.
Journal of Neurosurgery|December 9, 2017
Negative surgical exploration in patients with Cushing's disease: benefit of two-thirds gland resection on remission rate and a review of the literatureSteven B Carr, Bette K Kleinschmidt-DeMasters, Janice M Kerr, et al.
Endocrine|August 18, 2014
Growth hormone tumor histological subtypes predict response to surgical and medical therapyKatja Kiseljak-Vassiliades, Nichole E Carlson, Manuel T Borges, et al.
Endocrinology|October 15, 2005
The proliferative status of thyrotropes is dependent on modulation of specific cell cycle regulators by thyroid hormoneWhitney W Woodmansee, Janice M Kerr, Elizabeth A Tucker, et al.
Clinicoeconomics and Outcomes Research : CEOR|March 13, 2024
Medical Costs Associated with High/Moderate/Low Likelihood of Adult Growth Hormone Deficiency: A Healthcare Claims Database AnalysisKevin C J Yuen, Lewis S Blevins, David R Clemmons, et al.
Frontiers in Endocrinology|August 2, 2021
Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 StudyRosario Pivonello, Irina Bancos, Richard A Feelders, et al.
Frontiers in Endocrinology|May 16, 2022
Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 StudyRosario Pivonello, Irina Bancos, Richard A Feelders, et al.
International Journal of Endocrinology|June 28, 2022
Development of a Novel Algorithm to Identify People with High Likelihood of Adult Growth Hormone Deficiency in a US Healthcare Claims DatabaseKevin C J Yuen, Anna Camilla Birkegard, Lewis S Blevins, et al.
Molecular and Cellular Endocrinology|September 23, 2015
Differential somatostatin receptor (SSTR) 1-5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumorsKatja Kiseljak-Vassiliades, Mei Xu, Taylor S Mills, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Endocrine|March 22, 2012
Clinical implications of growth hormone-secreting tumor subtypesKatja Kiseljak-Vassiliades, Shibana Shafi, Janice M Kerr, et al.
Journal of Neurosurgery|August 31, 2010
Transsphenoidal resection of 82 Rathke cleft cysts: limited value of alcohol cauterization in reducing recurrence ratesKevin O Lillehei, Lars Widdel, Carolina A Arias Astete, et al.
Journal of Neurosurgery|December 9, 2017
Negative surgical exploration in patients with Cushing's disease: benefit of two-thirds gland resection on remission rate and a review of the literatureSteven B Carr, Bette K Kleinschmidt-DeMasters, Janice M Kerr, et al.
Endocrine|August 18, 2014
Growth hormone tumor histological subtypes predict response to surgical and medical therapyKatja Kiseljak-Vassiliades, Nichole E Carlson, Manuel T Borges, et al.
Endocrinology|October 15, 2005
The proliferative status of thyrotropes is dependent on modulation of specific cell cycle regulators by thyroid hormoneWhitney W Woodmansee, Janice M Kerr, Elizabeth A Tucker, et al.
Clinicoeconomics and Outcomes Research : CEOR|March 13, 2024
Medical Costs Associated with High/Moderate/Low Likelihood of Adult Growth Hormone Deficiency: A Healthcare Claims Database AnalysisKevin C J Yuen, Lewis S Blevins, David R Clemmons, et al.
Frontiers in Endocrinology|August 2, 2021
Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 StudyRosario Pivonello, Irina Bancos, Richard A Feelders, et al.
Frontiers in Endocrinology|May 16, 2022
Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 StudyRosario Pivonello, Irina Bancos, Richard A Feelders, et al.
International Journal of Endocrinology|June 28, 2022
Development of a Novel Algorithm to Identify People with High Likelihood of Adult Growth Hormone Deficiency in a US Healthcare Claims DatabaseKevin C J Yuen, Anna Camilla Birkegard, Lewis S Blevins, et al.
Molecular and Cellular Endocrinology|September 23, 2015
Differential somatostatin receptor (SSTR) 1-5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumorsKatja Kiseljak-Vassiliades, Mei Xu, Taylor S Mills, et al.
Pageof 3